Get started
SSS

Seelos Therapeutics, Inc.

No trades
See on Supercharts
Overview
Financials Discussions Technicals Seasonals

SEELQ chart


Full chart

SEELQ upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪398.37 K‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
0.0020
Basic EPS (TTM)
211.3075 USD
Net income (FY)
‪−37.88 M‬ USD
Revenue (FY)
‪2.20 M‬ USD
Shares float
‪1.12 M‬
Beta (1Y)
1.91

Employees


Employees (FY)
16
Change (1Y)
0
Revenue / Employee (1Y)
‪137.69 K‬ USD
Net income / Employee (1Y)
‪−2.37 M‬ USD

About Seelos Therapeutics, Inc.


Sector
Health Technology
Industry
Biotechnology
CEO
Raj Mehra
Website
seelostherapeutics.com
Headquarters
New York
Founded
1987
FIGI
BBG000BZ9W18
Seelos Therapeutics, Inc. is a clinical-stage biopharmaceutical company. It engages in the development of products that address significant unmet needs in Central Nervous System (CNS) disorders and other rare disorders. The company was founded by Raj Mehra in 1987 and is headquartered in New York, NY.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of SEELQ is 0.3800 USD — it has decreased by −2.56% in the past 24 hours. Watch Seelos Therapeutics, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Seelos Therapeutics, Inc. stocks are traded under the ticker SEELQ.
SEELQ stock has fallen by −49.50% compared to the previous week, the month change is a −62.38% fall, over the last year Seelos Therapeutics, Inc. has showed a −100.00% decrease.
SEELQ stock is 30.00% volatile and has beta coefficient of 1.91. Track Seelos Therapeutics, Inc. stock price on the chart and check out the list of the most volatile stocks — is Seelos Therapeutics, Inc. there?
Yes, you can track Seelos Therapeutics, Inc. financials in yearly and quarterly reports right on TradingView.
Seelos Therapeutics, Inc. is going to release the next earnings report on Nov 21, 2024. Keep track of upcoming events with our Earnings Calendar.
SEELQ net income for the last quarter is ‪1.71 M‬ USD, while the quarter before that showed ‪−2.66 M‬ USD of net income which accounts for 164.19% change. Track more Seelos Therapeutics, Inc. financial stats to get the full picture.
No, SEELQ doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 21, 2024, the company has 16.00 employees. See our rating of the largest employees — is Seelos Therapeutics, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Seelos Therapeutics, Inc. EBITDA is ‪−29.75 M‬ USD, and current EBITDA margin is ‪−1.84 K‬%. See more stats in Seelos Therapeutics, Inc. financial statements.
Like other stocks, SEELQ shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Seelos Therapeutics, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Seelos Therapeutics, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Seelos Therapeutics, Inc. stock shows the sell signal. See more of Seelos Therapeutics, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.